Related Experiment Video

Updated: Jun 13, 2026

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
05:10

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Published on: October 3, 2010

Protein kinase A regulatory subunit distribution in medulloblastoma

Carla Mucignat-Caretta1, Luca Denaro, Marco Redaelli

  • 1Department of Human Anatomy and Physiology, University of Padova, Padua, Italy. carla.mucignat@unipd.it

BMC Cancer
|April 20, 2010
PubMed
Abstract

Insights

Regulatory subunits of cAMP-dependent protein kinases (PKA) show distinct patterns in pediatric brain tumors. Medulloblastomas exhibit unique R2 subunit organization and cAMP labeling, differentiating them from other tumor types.

Area of Science:

  • Neuroscience
  • Oncology
  • Molecular Biology

Background:

  • Previous research indicated differential distribution of cAMP-dependent protein kinase regulatory subunits in the brain.
  • These distributions were altered in rodent gliomas, suggesting their potential as indicators of cellular functional states.

Purpose of the Study:

  • To investigate human brain tumors for evidence of differential distribution of protein kinase A (PKA) subunits.
  • To characterize the distribution patterns of PKA subunits in various pediatric brain tumor types.

Main Methods:

  • Immunohistochemistry was employed to examine the distribution of detergent-insoluble regulatory (R1 and R2) and catalytic subunits of cAMP-dependent kinases.
  • Fluorescent cAMP analogues binding was utilized to assess cAMP activity and localization within tumor cells.

Main Results:

  • The R2 subunit displayed a unique organization in large single dots specifically within medulloblastomas.
  • Other tumor types showed different organizational patterns for the R2 subunit.
  • Fluorescent cAMP labeling was exclusively detected in medulloblastomas.

Conclusions:

  • A distinct distribution pattern of cAMP-dependent protein kinases was identified in medulloblastoma.
  • These findings highlight potential differences in PKA signaling pathways between medulloblastomas and other pediatric brain tumors.

More Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells06:32

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Published on: September 1, 2010

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...